News

The FDA has started a priority review of Insmed's brensocatib, which is pitching to become the first approved therapy for bronchiectasis in the US.
Duchenne Muscular DystrophyTreatment From a Managed Care Perspective The relationship between health care payers and innovative muscular dystrophy therapies presents complex challenges that ...
Long-term results from the phase 2 OVARIO trial (NCT03326193) highlight the effectiveness of niraparib plus bevacizumab as maintenance therapy in patients with advanced ovarian cancer.
There are many different types of doctors who could diagnose, treat, and manage medical conditions. Learn more about the specialties and who to see.
Certain medical conditions may prevent you from being conscripted if WW3 breaks out (Stock image) (Image: Peter Byrne/PA Wire) ...
Sanofi is preparing a phase 3 programme for asthma candidate amlitelimab, despite mixed data in a phase 2 trial.
Bronchiectasis affects as many as half a million adults in the United States, yet many people have never heard of it. Even among those living with and treating the condition, there are often ...
Today, on World Bronchiectasis Day, the American Lung Association is launching a new campaign to support people living with bronchiectasis, which is a chronic and progressive lung condition that ...
Bronchiectasis, economic burden, non-cystic fibrosis bronchiectasis (NCFBE), treatment patterns. Each article is made available under the terms of the Creative Commons Attribution-Non Commercial 4.0 ...
Standard treatment for bronchiectasis comprises postural drainage and various regimes of antibiotic therapy. If the disease is confined to localised areas of lung, surgical resection of the affected ...
Introduction Bronchiectasis is a chronic, progressive lung condition which has significant effects on quality of life (QOL). Quick patient reported outcome measures (PROMs) measuring QOL are limited ...
Leukotriene receptor antagonists are a new class of drug which may have an anti-inflammatory action in some patients with asthma. In theory they may also be of benefit in bronchiectasis, but no ...